Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Risk estimation and prediction by modeling the transmission of the novel coronavirus (COVID-19) in mainland China excluding Hubei province

Hui Wan, Jing-an Cui, Guo-jing Yang
doi: https://doi.org/10.1101/2020.03.01.20029629
Hui Wan
1Jiangsu Key Laboratory for NSLSCS, School of Mathematics, Nanjing Normal University, Nanjing, P.R. China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: wanh2046{at}163.com cuijingan{at}bucea.edu.cn guojingyang{at}hotmail.com
Jing-an Cui
2Department of Mathematics, School of Science, Beijing University of Civil Engineering and Architecture, Beijing, P.R. China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: wanh2046{at}163.com cuijingan{at}bucea.edu.cn guojingyang{at}hotmail.com
Guo-jing Yang
3Swiss Tropical and Public Health Institute, Socinstrasse 57, CH-4002 Basel, Switzerland
4University of Basel, Basel, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: guojingyang{at}hotmail.com wanh2046{at}163.com cuijingan{at}bucea.edu.cn
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Background In December 2019, an outbreak of coronavirus disease (COVID-19) was identified in Wuhan, China and, later on, detected in other parts of China. Our aim is to evaluate the effectiveness of the evolution of interventions and self-protection measures, estimate the risk of partial lifting control measures and predict the epidemic trend of the virus in mainland China excluding Hubei province based on the published data and a novel mathematical model.

Methods A novel COVID-19 transmission dynamic model incorporating the intervention measures implemented in China is proposed. COVID-19 daily data of mainland China excluding Hubei province, including the cumulative confirmed cases, the cumulative deaths, newly confirmed cases and the cumulative recovered cases for the period January 20th-March 3rd, 2020, were archived from the National Health Commission of China (NHCC). We parameterize the model by using the Markov Chain Monte Carlo (MCMC) method and estimate the control reproduction number Rc, as well as the effective daily reproduction ratio Re(t), of the disease transmission in mainland China excluding Hubei province.

Results The estimation outcomes indicate that Rc is 3.36 (95% CI 3.20-3.64) and Re(t) has dropped below 1 since January 31st, 2020, which implies that the containment strategies implemented by the Chinese government in mainland China excluding Hubei province are indeed effective and magnificently suppressed COVID-19 transmission. Moreover, our results show that relieving personal protection too early may lead to the spread of disease for a longer time and more people would be infected, and may even cause epidemic or outbreak again. By calculating the effective reproduction ratio, we prove that the contact rate should be kept at least less than 30% of the normal level by April, 2020.

Conclusions To ensure the epidemic ending rapidly, it is necessary to maintain the current integrated restrict interventions and self-protection measures, including travel restriction, quarantine of entry, contact tracing followed by quarantine and isolation and reduction of contact, like wearing masks, etc. People should be fully aware of the real-time epidemic situation and keep sufficient personal protection until April. If all the above conditions are met, the outbreak is expected to be ended by April in mainland China apart from Hubei province.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This work is supported by the National Natural Science Foundation of China (No.11971240 and No.11871093) and the NSF of the Jiangsu Higher Education Committee of China (No.17KJA110002)

Author Declarations

All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.

Yes

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

All data were obtained from the National Health Commission of China.

http://en.nhc.gov.cn/

  • Abbreviations

    COVID-19
    Corona Virus Disease 2019;
    NHCC
    National Health Commission of the People’s Republic of China;
    MCMC
    Markov Chain Monte Carlo method;
    R0
    Basic reproduction number;
    Rc
    Control reproduction number;
    Re(t)
    Effective daily reproduction ratio.
  • Copyright 
    The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
    Back to top
    PreviousNext
    Posted April 24, 2020.
    Download PDF
    Data/Code
    Email

    Thank you for your interest in spreading the word about medRxiv.

    NOTE: Your email address is requested solely to identify you as the sender of this article.

    Enter multiple addresses on separate lines or separate them with commas.
    Risk estimation and prediction by modeling the transmission of the novel coronavirus (COVID-19) in mainland China excluding Hubei province
    (Your Name) has forwarded a page to you from medRxiv
    (Your Name) thought you would like to see this page from the medRxiv website.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Share
    Risk estimation and prediction by modeling the transmission of the novel coronavirus (COVID-19) in mainland China excluding Hubei province
    Hui Wan, Jing-an Cui, Guo-jing Yang
    medRxiv 2020.03.01.20029629; doi: https://doi.org/10.1101/2020.03.01.20029629
    Twitter logo Facebook logo LinkedIn logo Mendeley logo
    Citation Tools
    Risk estimation and prediction by modeling the transmission of the novel coronavirus (COVID-19) in mainland China excluding Hubei province
    Hui Wan, Jing-an Cui, Guo-jing Yang
    medRxiv 2020.03.01.20029629; doi: https://doi.org/10.1101/2020.03.01.20029629

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    Subject Area

    • Infectious Diseases (except HIV/AIDS)
    Subject Areas
    All Articles
    • Addiction Medicine (430)
    • Allergy and Immunology (756)
    • Anesthesia (221)
    • Cardiovascular Medicine (3289)
    • Dentistry and Oral Medicine (364)
    • Dermatology (277)
    • Emergency Medicine (479)
    • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1170)
    • Epidemiology (13365)
    • Forensic Medicine (19)
    • Gastroenterology (898)
    • Genetic and Genomic Medicine (5152)
    • Geriatric Medicine (482)
    • Health Economics (782)
    • Health Informatics (3264)
    • Health Policy (1140)
    • Health Systems and Quality Improvement (1190)
    • Hematology (429)
    • HIV/AIDS (1017)
    • Infectious Diseases (except HIV/AIDS) (14624)
    • Intensive Care and Critical Care Medicine (912)
    • Medical Education (476)
    • Medical Ethics (127)
    • Nephrology (522)
    • Neurology (4922)
    • Nursing (262)
    • Nutrition (729)
    • Obstetrics and Gynecology (883)
    • Occupational and Environmental Health (795)
    • Oncology (2520)
    • Ophthalmology (723)
    • Orthopedics (281)
    • Otolaryngology (347)
    • Pain Medicine (323)
    • Palliative Medicine (90)
    • Pathology (543)
    • Pediatrics (1301)
    • Pharmacology and Therapeutics (550)
    • Primary Care Research (556)
    • Psychiatry and Clinical Psychology (4206)
    • Public and Global Health (7501)
    • Radiology and Imaging (1705)
    • Rehabilitation Medicine and Physical Therapy (1012)
    • Respiratory Medicine (980)
    • Rheumatology (479)
    • Sexual and Reproductive Health (497)
    • Sports Medicine (424)
    • Surgery (548)
    • Toxicology (72)
    • Transplantation (236)
    • Urology (205)